The surface charge of apolipoproteins, phospholipid liposomes, and human very low density lipoproteins. 1983

C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke

The surface charge of isolated apolipoprotein A-I, apo-A-II, apo-C-II, and apo-C-III2 as well as of liposomes from synthetic highly purified phospholipids and isolated very low density lipoprotein (VLDL) particles from different donors (n = 35) was determined by polyelectrolyte titration. The particle size of apolipoproteins was evaluated from their molecular weight and specific volume, while that of VLDL particles was determined by photon correlation spectroscopy. The surface charge density of apolipoproteins and of VLDL at pH 7 was calculated from the number of surface charges of the particle and the surface area. The experimental net charge versus pH curves for apo-A-I and apo-A-II are very similar to the theoretical data. The differences between experimental and calculated results for apo-C-II and apo-C-III2 are believed to result from "polyelectrolyte" effects of neighboring charged centers within the protein molecule causing a decrease of dissociation of carboxylic residues. Neutral phospholipid liposomes do not exhibit anionic or cationic properties between pH 3 and 9. Liposomes from anionic phospholipids behave similar to polymeric carboxylic acids, i.e. their degree of dissociation increases with pH. The number of surface charges of VLDL particles increases with the particle size, while their surface charge density is about 1.10 +/- 0.36 charges/nm2 of the surface area.

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D007477 Ions An atom or group of atoms that have a positive or negative electric charge due to a gain (negative charge) or loss (positive charge) of one or more electrons. Atoms with a positive charge are known as CATIONS; those with a negative charge are ANIONS.
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D001053 Apolipoproteins Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES. Apolipoprotein

Related Publications

C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
April 1983, Journal of lipid research,
C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
July 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
December 1970, The Journal of biological chemistry,
C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
January 1982, The International journal of biochemistry,
C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
April 1979, Experimental and molecular pathology,
C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
February 1986, The Journal of biological chemistry,
C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
January 1974, Atherosclerosis,
C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
July 2002, The American journal of cardiology,
C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
January 1986, Acta cientifica venezolana,
C C Heuck, and W Daerr, and W Haberbosch, and D Horn, and E Lüddecke
April 1979, Biochimica et biophysica acta,
Copied contents to your clipboard!